Kenneth Bahrt is SVP & Chief Medical Officer at SAVIENT PHARMACEUTICALS INC (SVNT). They have made 4 open-market trades across 2 companies since 2011, most recently 2018-06-25.
CIK 0001527197
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $25K since 2011, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ONS | SELL | 2018-06-25 | 2018-06-27 | $0.85 | $7K | -0.3% | +1.4% | +14.9% |
| ONS | SELL · Routine | 2017-12-22 | 2017-12-26 | $1.13 | $30K | +4.1% | +0.8% | -22.1% |
| SVNT | SELL | 2013-10-15 | 2013-10-17 | $0.08 | $6K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2013-04-30 | 2013-05-01 | $0.74 | $925 | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2013-02-04 | 2013-02-06 | $1.03 | $30K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2013-01-31 | 2013-02-04 | $1.03 | $1K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2012-10-31 | 2012-11-06 | $1.45 | $1K | N/A | N/A | N/A |
| SVNT | SELL · 10b5-1 | 2012-08-01 | 2012-08-03 | $0.62 | $3K | N/A | N/A | N/A |
| SVNT | BUY | 2011-11-16 | 2011-11-18 | $2.59 | $13K | N/A | N/A | N/A |
| SVNT | BUY | 2011-09-14 | 2011-09-16 | $3.95 | $12K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.